Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-01T13:49:02.862Z Has data issue: false hasContentIssue false
  • English
  • Français

Pseudomonas aeruginosa

Published online by Cambridge University Press:  02 January 2015

Charles W. Stratton
Charles W. Stratton*
Affiliation:
Clinical Microbiology, Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 4 , Issue 1 , February 1983 , pp. 36 - 40
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gessard, C, Sur les colorations bleue et verte des linges a pansements. Compt Rend Acad Sci 1882;94:536.Google Scholar
2.Charrin, A, La maladie pyocyanique. Paris, 1889.Google Scholar
3.Kessner, DM, Lepper, MH, Epidemiologie studies of gram-negative bacilli in the hospital and community. Am J Epidemiol 1967;85:45–60.CrossRefGoogle Scholar
4.Rosenthal, S, Tager, IB, Prevalence of gram-negative rods in the normal pharyngeal flora. Ann Intern Med 1975;83:355–357.CrossRefGoogle ScholarPubMed
5.Bruun, JN, McGarity, GJ, Blakemore, WS, et al: Epidemiology of Pseudomonas aeruginosa infections: Determination by pyocin typing. J Clin Microbiol 1976;3:264–271.CrossRefGoogle ScholarPubMed
6.Kominos, SD, Copeland, CE, Grosiak, B, et al: Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Applied Microbiology 1972;24:567–570.CrossRefGoogle ScholarPubMed
7.Hurst, V, Sutter, VL, Survival of Pseudomonas aeruginosa infection in the hospital environment. J Inject Dis 1966;116:151–154.CrossRefGoogle ScholarPubMed
8.Shooter, RA, Cooke, EM, Kumar, P, et al: Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet 1969;1:1227–1229.CrossRefGoogle ScholarPubMed
9.Grieble, HG, Colton, FR, Bird, TJ, et al: Fine particle humidifiers: Source of Pseudomonas aeruginosa infections in a respiratory disease unit. N Engl J Med 1970;282:531–535.CrossRefGoogle Scholar
10.Favero, MS, Carson, LA, Bond, WW, et al: Pseudomonas aeruginosa: Growth in distilled water from hospitals. Science 1971;173:836–838.CrossRefGoogle ScholarPubMed
11.Whitby, JL, Rampling, A, Pseudomonas aeruginosa contamination in domestic and hospital environments. Lancet 1972;1:15–17.CrossRefGoogle ScholarPubMed
12.Teres, D, Schweers, P, Bushneil, LS, et al: Sources of Pseudomonas aeruginosa infection in a respiratory/surgical intensive therapy unit. Lancet 1973;1:415–417.CrossRefGoogle Scholar
13.Hugh, R, Gilardi, G, Pseudomonas, in Lennette, EH, Balows, A, Hausler, WJ Jr, et al (eds): Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1980, p 288–317.Google Scholar
14.Liu, PV, Abe, Y, Bates, JL, The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J Infect Dis 1961;108:218–228.CrossRefGoogle ScholarPubMed
15.Young, LS, Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides. J Infect Dis 1972;126:277–287.CrossRefGoogle ScholarPubMed
16.Alexander, JW, Fisher, MW, Macmillan, BG, et al: Prevention of invasive Pseudomonas infections in burns with a new vaccine. Arch Surg 1969;99:249–256.CrossRefGoogle ScholarPubMed
17.Liu, PV, Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis 1974;130(suppl):94–99.CrossRefGoogle ScholarPubMed
18.Scharmann, W, Jacob, F, Porstenorfer, J, The cytotoxic action of leucociden from Pseudomonas aeruginosa on human polymorphonuclear leukocytes. J Gen Microbiol 1976;93:303–308.CrossRefGoogle Scholar
19.Young, LS, Armstrong, D, Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis 1972;126:257–276.CrossRefGoogle ScholarPubMed
20.Schwarzmann, S, Boring, JR, Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect Immun 1971;3:762–767.CrossRefGoogle ScholarPubMed
21.Zak, D, Antibiotics and Pseudomonas aeruginosa, in Sabath, LD (ed): Pseudomonas aeruginosa: The Organism, Diseases it Causes, and Their Treatment. Bern, Switzerland, Huber, 1980, p 133–159.Google Scholar
22.Jackson, GG, Riff, LJ, Pseudomonas bacteremia: Pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis 1971;124(suppl):5185–5191.CrossRefGoogle ScholarPubMed
23.Flick, MR, Cluff, LE, Pseudomonas bacteremia: Reviewof 108 cases. Am J Med 1976;60:501–508.CrossRefGoogle Scholar
24.Andriole, VT, Pseudomonas bacteremia: Can antibiotic therapy improve survival? J Lab Clin Med 1979;94:196–200.Google ScholarPubMed
25.Woolfrey, BF, Fox, JM, Quail, CO, A comparison of minimal inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am J Clin Pathol 1981;75:39–44.CrossRefGoogle Scholar
26.Garrod, LP, Waterworth, PM, Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol 1969;22:534–538.CrossRefGoogle ScholarPubMed
27.Gilbert, DM, Kutscher, E, Ireland, P, et al: Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin. J Infect Dis 1971;124(suppl):37–45.CrossRefGoogle ScholarPubMed
28.Reller, LB, Schoenknecht, FD, Kenny, MA, et al: Antibiotic susceptibility testing of Pseudomonas aeruginosa: Selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis 1974;130:454–463.CrossRefGoogle ScholarPubMed
29.Etowski, DC, Beckwith, DG, Performance of a commercial microdilution minimal inhibitory concentration procedure for aminoglycoside susceptibility testing of Pseudomonas aeruginosa. Am J Clin Pathol 1981;75:830–833.CrossRefGoogle ScholarPubMed
30.Peterson, LR, Ceding, DN, Johnson, MM, et al: Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multi-drug-resistant, gram-negative bacilli. Antimicrob Agents Chemother 1980;17:20–23.CrossRefGoogle Scholar
31.Nicas, TI, Bryan, LE, Relationship between gentamicin susceptibility criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection mode. Antimicrob Agents Chemother 1978;13:796–801.CrossRefGoogle Scholar
32.David, SD, Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1974;5:281–283.Google Scholar
33.Reyes, MP, Palutke, WA, Wylin, RF, et al: Pseudomonas endocarditis in the Detroit Medical Center, 1969-1972. Medicine 1973;52:173–190.CrossRefGoogle ScholarPubMed
34.Reyes, MP, Brown, WJ, Lerner, AM, Treatment of patients with Pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine 1978;57:57–67.CrossRefGoogle ScholarPubMed
35.Greenwood, D, Eley, A, A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudo-monal β-lactam agents. Antimicrob Agents Chemother 1982;145:110–117.Google Scholar
36.Greenwood, D, Eley, A, Comparative antipseudomonal activity of some newer β-lactam agents. Antimicrob Agents Chemother 1982;21:204–209.CrossRefGoogle ScholarPubMed
37.Corrado, ML, Landesman, SH, Cherubin, CE, Influenceof inoc ulum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Antimicrob Agents Chemother 1980;18:893–896.CrossRefGoogle Scholar
38.White, AR, Comber, KR, Sutherland, R, Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 1980;18:182–189.CrossRefGoogle ScholarPubMed
39.Rodriguez-Tebar, A, Rojo, F, Damaso, D, et al: Carbenicillin resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1982;222:255–261.CrossRefGoogle Scholar
40.Then, RL, Angehrn, P, Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob Agents Chemother 1982;21:711–717.CrossRefGoogle ScholarPubMed
41.Lowbury, EJL, Lilly, HA, Kidson, A, et al: Sensitivity of Pseudomonas aeruginosa to antibiotics: Emergence of strains highly resistant to carbenicillin. Lancet 1969;2:448–452.CrossRefGoogle ScholarPubMed
42.Keyes, MP, Lorner, AM, Failure in the treatment of Pseudomonas infective endocarditis with concomitant induction of beta-lactamase. Presented at the 21st interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1981, abstract 105.Google Scholar
43.Simon, GL, Snydman, DR, Tally, FP, et al: Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. Antimicrob Agents Chemother 1980;18:167–170.CrossRefGoogle ScholarPubMed
44.Platt, R, Ehrlich, SL, Afarian, J, Moxalactam therapy of infections caused by cephalothin-resistant bacteria: Influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance. Antimicrob Agents Chemother 1981;20:351–355.CrossRefGoogle ScholarPubMed
45.Kenny, MA, Pollock, HM, Minshew, BH, et al: Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother 1980;17:55–62.CrossRefGoogle ScholarPubMed
46.Casillas, E, Kenny, MA, Minshew, BH, et al: Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin. Antimicrob Agents Chemother 1981;19:987–992.CrossRefGoogle ScholarPubMed
47.Woolfrey, BF, Fox, JM, Quail, CO, An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides. Am J Clin Pathol 1981;75:559–564.CrossRefGoogle ScholarPubMed
48.Woolfrey, BF, Ramadei, WA, Quail, CO, Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin. Am J Clin Pathol 1978;70:337–342.CrossRefGoogle ScholarPubMed
49.Mayo, JB, Kiehn, T, Wong, B, et al: Examination of Pseudomonas afruginosa-gentamicin discrepancies encountered in an Autobac I-disc diffusion comparison. Antimicrob Agents Chemother 1982;21:412–415.CrossRefGoogle Scholar
50.Lanyi, B, Bergan, T, Serological characterization of Pseudomonas aeruginosa, in Bergan, T, Norris, JR (eds): Methods in Microbiology. London, Academic Press, 1978, vol 10, p 93–168.Google Scholar
51.Bobo, RA, Newton, EJ, Jones, LF, et al: Nursery outbreaks of Pseudomonas aeruginosa: Epidemiological conclusions from five different typing methods. Applied Microbiology 1973;25:414–420.CrossRefGoogle ScholarPubMed
52.Lindberg, RB, Latta, RL, Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations. J Infect Dis 1974;130:533–542.CrossRefGoogle ScholarPubMed
53.Bergan, T, Phage typing of Pseudomonas aeruginosa, in Bergan, T, Norris, JR (eds): Methods in Microbiology. London, Academic Press, 1978, vol 10, p 169–199.Google Scholar
54.Govan, JRW, Pyocin typing of Pseudomonas aeruginosa, in Bergan, T, Norris, JR (eds): Methods in Microbiology. London, Academic Press, 1978, vol 10, p 61–91.Google Scholar